Protagonist Therapeutics, Inc. (PTGX): Price and Financial Metrics
Protagonist Therapeutics, Inc. (PTGX)
Today's Latest Price: $18.95 USD
Updated Oct 30 4:00pm
Add PTGX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
PTGX Stock Summary
- Of note is the ratio of Protagonist Therapeutics Inc's sales and general administrative expense to its total operating expenses; just 9.38% of US stocks have a lower such ratio.
- With a price/sales ratio of 41.71, Protagonist Therapeutics Inc has a higher such ratio than 95.35% of stocks in our set.
- Revenue growth over the past 12 months for Protagonist Therapeutics Inc comes in at 808.42%, a number that bests 99.08% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Protagonist Therapeutics Inc, a group of peers worth examining would be XENE, NXTC, ALPN, MGNX, and FULC.
- Visit PTGX's SEC page to see the company's official filings. To visit the company's web site, go to www.protagonist-inc.com.
PTGX Stock Price Chart Interactive Chart >
PTGX Price/Volume Stats
| Current price | $18.95 | 52-week high | $23.25 |
| Prev. close | $18.49 | 52-week low | $4.47 |
| Day low | $17.44 | Volume | 322,900 |
| Day high | $19.25 | Avg. volume | 506,011 |
| 50-day MA | $20.79 | Dividend yield | N/A |
| 200-day MA | $14.14 | Market Cap | 697.49M |
Protagonist Therapeutics, Inc. (PTGX) Company Bio
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded in 2006 and is based in Milpitas, California.
Loading social stream, please wait...